Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Inventory Average (2023 - 2026)

TriSalus Life Sciences has reported Inventory Average over the past 4 years, most recently at $3.4 million for Q1 2026.

  • For Q1 2026, Inventory Average fell 16.5% year-over-year to $3.4 million; the TTM value through Mar 2026 reached $3.4 million, down 16.5%, while the annual FY2025 figure was $3.6 million, 8.07% up from the prior year.
  • Inventory Average for Q1 2026 was $3.4 million at TriSalus Life Sciences, up from $3.2 million in the prior quarter.
  • Over five years, Inventory Average peaked at $4.1 million in Q1 2025 and troughed at $2.1 million in Q4 2023.
  • A 4-year average of $3.4 million and a median of $3.5 million in 2025 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: surged 92.79% in 2024 and later decreased 21.05% in 2025.
  • Year by year, Inventory Average stood at $2.1 million in 2023, then skyrocketed by 92.79% to $4.0 million in 2024, then decreased by 21.05% to $3.2 million in 2025, then grew by 7.9% to $3.4 million in 2026.
  • Business Quant data shows Inventory Average for TLSI at $3.4 million in Q1 2026, $3.2 million in Q4 2025, and $3.5 million in Q3 2025.